Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-10-17

FDA Approved: PERINDOPRIL ERBUMINE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for PERINDOPRIL ERBUMINE from Aurobindo Pharma Limited (ANDA) to market the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Perindopril erbumine (perindopril erbumine)

Snippet

SUPPL AP for PERINDOPRIL ERBUMINE (PERINDOPRIL ERBUMINE)